Aerami Therapeutics Holdings, Inc. Durham, North Carolina, 27713Merger Agreement • March 4th, 2022 • FoxWayne Enterprises Acquisition Corp. • Pharmaceutical preparations
Aerami Therapeutics Holdings, Inc. and FoxWayne Enterprises Acquisition Corp. Mutually Agree to Terminate Business Combination AgreementBusiness Combination Agreement • March 4th, 2022 • FoxWayne Enterprises Acquisition Corp. • Pharmaceutical preparations
DURHAM, N.C. and NEW YORK, N.Y. – March 4, 2022 – Aerami Therapeutics Holdings, Inc. (“Aerami”), a biopharmaceutical company focused on developing inhaled therapies to treat severe respiratory and chronic diseases, and FoxWayne Enterprises Acquisition Corp. (NASDAQ: FOXW) (“FoxWayne”), a publicly traded special purpose acquisition company (“SPAC”), announced today that they have mutually agreed to terminate their previously announced business combination agreement, effective immediately.
